Drug
Xl844
Xl844: highest development phase Phase 1, developed by Exelixis. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Exelixis
Trials
| Drug | Phase | Indication |
|---|---|---|
| XL844 NCT00475917 | Phase 1 | Cancer |
Latest
No recent events.
Follow Xl844 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.